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Abstract
Protein post-translational modifications (PTMs) are regulated separately from protein expression levels. Thus, simultaneous
characterization of the proteome and its PTMs is pivotal to an understanding of protein regulation, function and activity.
However, concurrent analysis of the proteome and its PTMs by mass spectrometry is a challenging task because the
peptides bearing PTMs are present in sub-stoichiometric amounts and their ionization is often suppressed by unmodified
peptides of high abundance. We describe here a method for concurrent analysis of phosphopeptides, glycopeptides and
unmodified peptides in a tryptic digest of rat kidney tissue with a sequence of ERLIC and RP-LC-MS/MS in a single
experimental run, thereby avoiding inter-experimental variation. Optimization of loading solvents and elution gradients
permitted ERLIC to be performed with totally volatile solvents. Two SCX and four ERLIC gradients were compared in details,
and one ERLIC gradient was found to perform the best, which identified 2929 proteins, 583 phosphorylation sites in 338
phosphoproteins and 722 N-glycosylation sites in 387 glycoproteins from rat kidney tissue. Two hundred low-abundance
proteins with important functions were identified only from the glyco- or phospho-subproteomes, reflecting the
importance of the enrichment and separation of modified peptides by ERLIC. In addition, this strategy enables identification
of unmodified and corresponding modified peptides (partial phosphorylation and N-glycosylation) from the same protein.
Interestingly, partially modified proteins tend to occur on proteins involved in transport. Moreover, some membrane or
extracellular proteins, such as versican core protein and fibronectin, were found to have both phosphorylation and N-
glycosylation, which may permit an assessment of the potential for cross talk between these two vital PTMs and their roles
in regulation.
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Introduction
As proteins and their modifications are directly involved in
nearly all biological processes, the identification and quantification
of as many proteins and their post-translational modifications
(PTMs) as possible from the same sample are the prerequisites for
biological discovery. As peptides are more compatible with liquid
chromatography (LC) separation and mass spectrometry (MS)
detection, protein extracts are usually digested with a protease to
yield a complex mixture of peptides in shotgun proteomics. To
thoroughly characterize the proteome, multidimensional protein
identification technology (MudPIT) [1] is commonly employed in
which multidimensional liquid chromatography (MDLC) is used
to reduce sample complexity and increase dynamic range of
protein identification, and separate experiments with different
types of enrichment methods are used for concentration of
peptides of low abundance with PTMs for mass spectrometric
characterization.
In recent years, considerable attention has been paid to the
study of information-rich subsets of the proteome, such as the
phosphoproteome and glycoproteome, in order to improve the
dynamic range of identified proteins [2]. It has been estimated that
about 50% of all proteins are glycosylated [3] and over one third
of all proteins are phosphorylated in mammals [4]. Phosphoryla-
tion is a dynamic and reversible modification involved in the
regulation of many biological processes including metabolism, cell
division, signal transduction and enzymatic activity [5–7].
Glycosylation also plays important roles in many biological
processes including embryonic development, cell-to-cell interac-
tions, cell division, and protein regulation and interaction [8].
Because of the frequently low stoichiometry of PTMs and the ion
suppression effect from unmodified peptides of high abundance,
phosphopeptides and glycopeptides have to be enriched before
MS analysis to minimize such suppression [9]. Immunoprecipita-
tion, immobilized metal affinity chromatography (IMAC), strong-
cation exchange (SCX) and titanium dioxide (TiO2) chromatog-
raphy have become popular for phosphopeptide enrichment [10–
13], and lectin-based affinity enrichment, hydrophilic interaction
liquid chromatography (HILIC), SCX and hydrazide covalent
chromatography have been extensively used in the enrichment of
glycoproteins or glycopeptides [14–18].
Regulatory protein phosphorylation is a dynamic modification
of low occupancy; many sites are only partially phosphorylated at
a given time. The phosphorylation of a protein has been found not
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Similarly, it has been reported that protein glycosylation changes
significantly during inflammation, sepsis and cancers [21,22]. The
determination of the stoichiometry of phosphorylation and
glycosylation at certain sites is helpful to understand the
mechanism of some regulatory pathways [23,24]. Furthermore,
downstream gene expression regulated by phosphorylation may
also include some unmodified proteins. Accordingly, appreciable
efforts have been made toward the analysis of the proteome and
phospho- and glycoproteomes. A method that permitted this to be
done simultaneously would be convenient and would provide
information on both protein expression and modification.
Furthermore, the inter-experimental variation now resulted from
separate analysis of modified and unmodified peptides would be
avoided. Such an analysis has not been possible to date. Analysis of
phosphopeptides and glycopeptides requires their specific enrich-
ment from unmodified peptides as well as their fractionation. The
analysis of the proteome overall requires comprehensive fraction-
ation to reduce sample complexity, but unmodified peptides tend
to elute in the flow-through in methods that selectively enrich the
concentration of modified peptides. It is very difficult to achieve
both types of separations in one analysis. In this study we propose
to do so using electrostatic repulsion-hydrophilic interaction
chromatography (ERLIC).
ERLIC was first introduced by Alpert for separation of
biomolecules and phosphopeptide enrichment [25]. It has since
been extended to the enrichment of phosphopeptides from cell
extracts and fractionation of N-linked glycopeptides from complex
samples [26–28]. Recently, the simultaneous characterization of
the glycoproteome and phosphoproteome of mouse brain
membrane has been achieved with ERLIC [29]. By performing
gradient elution with unbuffered acids, ERLIC was optimized for
whole proteome fractionation [30]. In the present study the
conditions for ERLIC have been optimized further so that for the
first time, the simultaneous analysis of proteome, phosphopro-
teome and glycoproteome has been achieved in one run. Since
SCX and ERLIC have both been used for fractionation of both
modified and unmodified peptides to some extent, they were
compared here in detail for the analysis of tryptic peptides of rat
kidney tissue.
Materials and Methods
Ethics Statement
The use of rat kidneys for proteomics research was approved by
the Institutional Animal Care and Use Committee of Nanyang
Technological University (NTU-IACUC) with the reference
number of ARF SBS/NIE-A 0083.
Sample Preparation and Digestion
Male Sprague Dawley rats (230–250g) were kept in a
temperature-controlled environment (24uC) on a 12-h light:12-h
dark cycle with free access to food and water. Animals were
handled in accordance with the guidelines of NTU Institutional
Animal Care and Use Committee (NTU-IACUC), NTU,
Singapore. The animals were sacrificed under deep anesthesia
and transcardially perfused with 300 ml of ice-cold PBS to flush
out the blood from the circulatory system. The kidney was
subsequently collected, snap-frozen in liquid nitrogen and kept at
280uC until use. The tissue was cut into small pieces and ground
into fine powders in liquid nitrogen with a pestle. The powders
were then suspended in lysis buffer (8 M urea, 50 mM Tris-HCl,
pH 8.0) with protease inhibitor cocktail (P8340, Sigma) and
phosphatase inhibitors (04906837001, Roche) added according to
the manufacturers’ instructions. The suspension was sonicated for
10 s thrice on ice and centrifuged at 20 000 g at 4uC for 30 min.
The protein concentration of the supernatant was then determined
by the bicinchoninic acid (BCA) assay. About 20 mg of sample
lysate was reduced with 20 mM DTT at 37uC for 3–4 h and
alkylated with 80 mM iodoacetamide for 45 min in the dark. After
the concentration of urea was diluted to 1 M with 50 mM
NH4HCO3, trypsin was added at a ratio of 1:100 (trypsin/sample).
It was then incubated at 37uC for 4 h. For complete digestion,
incubation was continued at 37uC for about 12 h after a second
addition of the same amount of trypsin. The obtained tryptic
peptides were desalted using a Sep-Pak C18 artridge (Waters,
Milford, MA) and dried in a SpeedVac Thermo Electron,
Waltham, MA) [30].
ERLIC Separation
Peptides from 2 mg proteins were fractionated using a
PolyWAX LP weak anion-exchange column (4.66200 mm,
5 mm, 300 A ˚, PolyLC, Columbia, MD) on a Shimadzu Promi-
nence UFLC system. Forty six fractions were collected with a
140 min gradient of 100% buffer A for 10 min, 0%–8% buffer B
for 20 min, 8%–27% buffer B for 30 min, 27%–45% buffer B for
10 min, 45%–81% buffer B for 20 min and 81%–100% buffer B
for 20 min followed by 30 min at 100% buffer B at a flow rate of
0.5 mL/min. To optimize the ERLIC condition for simultaneous
characterization of the overall proteome and peptides with the two
specific PTMs, four different combinations of Buffer A and Buffer
B were used in the ERLIC separation: ERLIC01, 10 mM
ammonium formate in 90% ACN, pH 2.6 and 25% ACN, 2%
formic acid (FA); ERLIC02, 10 mM ammonium formate in 90%
ACN, pH 3.9 and 25% ACN, 2% FA; ERLIC03, 85% ACN,
0.05% FA and 25% ACN, 2% FA; ERLIC04, 80% ACN, 0.1%
FA and 10% ACN, 2% FA. The collected fractions were then
dried with a vacuum centrifuge.
SCX Separation
This was performed with peptides from 2 mg protein in
replicate as previously described except that the pH of the mobile
phases was 2.7, not 3.0 [30].
PNGase F Treatment
The SCX- and ERLIC-fractionated peptides were redissolved
in 25 mM NH4HCO3. To the solution, about 15 units of PNGase
F (P0705L, New England Biolabs Inc.) were added and incubated
at 37uC for 5 h for complete deglycosylation. After the
glycopeptides are digested with PNGase F, the NH2 group in
asparagine changes into OH group at the glycosylation site (i.e.
deamidation of asparagine) so that the mass of deglycosylated
peptides increases 0.984 Dalton, which can be detected unambig-
uously by FTMS. However, the reaction can also happen
spontaneously due to in vivo deamidation or sample preparation.
Thus, an independent control was processed with the same
procedure except without adding PNGase F to the sample for
estimation of false positive identifications of glycosylation sites by
measuring the number of pre-existing sites of deamidation. They
were then dried with a vacuum centrifuge and redissolved in
100 mL 0.1% FA for LC-MS/MS analysis.
LC-MS/MS
The deglycosylated peptides were separated and analyzed on a
Shimadzu UFLC system coupled to a LTQ-FT Ultra (Thermo
Electron, Bremen, Germany). One third of the peptides in each
fraction were injected into a Zorbax peptide trap column (Agilent,
Proteome, Phospho and Glyco-Proteome Analysis by ERLIC
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desalting. The peptides were separated in a capillary column
(200 mm 610 cm) packed with C18 AQ (5 mm, 300 A ˚, Michrom
BioResources, Auburn, CA, USA) at a flow rate of 500 nl/min.
Mobile phase A (0.1% FA in H2O) and mobile phase B (0.1% FA
in acetonitrile) were used to establish the 60 min gradient
comprised of 45 min of 8–35% B, 8 min of 35–50% B and
2 min of 80% B followed by re-equilibrating at 5% B for 5 min.
The peptides were then analyzed on LTQ-FT with an
ADVANCE
TM CaptiveSpray
TM Source (Michrom BioResources)
at an electrospray potential of 1.5 kV. A gas flow of 2, ion transfer
tube temperature of 180uC and collision gas pressure of 0.85
mTorr were used. The LTQ-FT was set to perform data
acquisition in the positive ion mode as previously described except
that the m/z range of 350–1600 was used in the full MS scan [27].
Data Analysis
The raw data were first converted into the dta format using the
extract_msn(version 4.0)in Bioworks Browser (version 3.3, Thermo
Fisher Scientific Inc), and then the dta files were converted into
Mascot generic file format using an in-house program as described
[31]. Intensity values and fragment ion m/z ratios were not
manipulated. The IPI rat protein database (version 3.40, 40381
sequences, 20547209 residues) and its reversed complement were
combined and used for database searches. The database search was
performed using an in-house Mascot server (version 2.2.04, Matrix
Science, Boston, MA, USA) with MS tolerance of 5 ppm and MS/
MS tolerance of 0.5 Da. Two missed cleavage sites of trypsin were
allowed. Carbamidomethylation (C) was set as a fixed modification,
and oxidation (M), phosphorylation (S, T and Y) and deamidation
(N) were set as variable modifications. The obtained peptide/
protein list for each fraction was either exported to Microsoft Excel
or processed using an in-house script for further analysis. The dta
files of peptides of which the Mascot score was over 20 in each
fraction were combined and converted into Mascot generic file
format using an in-house program. It was then searched again using
Mascot to generate the protein list for false discovery rates (FDR)
evaluation. FDRs were evaluated according to the target-decoy
strategy as previously described [32] and were set to 0.01. Peptides
identified with a consensus N-X-S/T (with X not proline) and a
modification of deamidation at asparagine were regarded as N-
linked glycopeptides. For high confidence peptide identification,
peptide matches were filtered with an expectation value of less than
0.05 in the Mascot search. After filtering, the FDRs of glycopeptide
and phosphopeptide identification were estimated to be less than
1% in each analysis.
Protein Classification and Functional Annotation
Proteins, phosphoproteins and glycoproteins identified in this
study were categorized according to their respective subcellular
locations and biological processes using the RGD database with
AmiGo Go Slimmer online annotation tools [33,34].
Results and Discussion
The mechanism of concurrent analysis of proteome,
phosphoproteome and glycoproteome in SCX and ERLIC
fractionations
As shown in Figure 1A and 1B, SCX and ERLIC fractionations
generate completely different chromatograms due to their different
separation principles. When SCX fractionation is conducted at
pH 2.7, most of the tryptic peptides carry a net charge of +2 due to
the positive charge at the C-terminal arginine/lysine and at their
N-terminus [35]. Because of the negative charge from a phosphate
group or sialic acid, most mono-phosphorylated peptides and
mono-sialylated glycopeptides have a net charge of +1 and so are
less well-retained by SCX materials and elute before most
unmodified peptides [17]. Most multi-phosphorylated peptides
and multi-sialylated glycopeptides are neutral or negatively
charged and elute even earlier, frequently in the flow-through.
Thus, unmodified peptides are separated from phosphopeptides
and sialylated glycopeptides to a significant extent, and concurrent
analysis of proteome, phosphoproteome and glycoproteome is
potentially achieved in one run (Figure 1C-1E). Practically
speaking, this approach is not completely successful. Peptides
eluted in the flow-through are difficult to identify without further
fractionation. Also, only about 30% of the phosphopeptides in a
complex digest have a net charge of +1 or less at pH 2.7. The rest
are distributed throughout the SCX gradient and so a second
enrichment step such as titania or IMAC affinity chromatography
is necessary to achieve good phosphopeptide identification.
ERLIC is a mixed-mode chromatography method that
separates peptides based on both charge and polarity. It can be
manipulated more effectively than SCX to achieve phosphopep-
tide and glycopeptide enrichment with simultaneous fractionation
of these two classes of modified peptides. They were characterized
simultaneously from a digest of mouse brain membrane but under
conditions where the unmodified peptides eluted in the flow-
through [29]. Also, the use of non-volatile salts in the gradient
buffers in that study required subsequent desalting of each fraction
with reverse phase C18 cartridges. That may have led to the loss of
some hydrophilic phosphopeptides [36]. In this study, no salts or
only volatile salts were used in the loading and elution solvents so
that desalting was not necessary for the ERLIC fractions, and the
pH and concentration of organic reagents in the buffers were also
optimized so that unmodified and modified peptides were all
retained and fractionated simultaneously. In ERLIC fractionation,
unmodified peptides with net charge of +2 in the pH range 2.6–3.9
are repelled electrostatically by the weak anion-exchange (WAX)
material but are still retained on the column with high organic
mobile phase through hydrophilic interaction. They can then be
distributed into multiple fractions during elution through the
simultaneous effect of electrostatic repulsion and a decrease in
hydrophilic interaction. Most of the unmodified peptides are
eluted from the column in the range of 80–65% ACN in the
gradient (Figure 1B and 1C). Phosphopeptides and glycopeptides
tend to elute after unmodified peptides due to their high
hydrophilicity plus the electrostatic attraction to the column by
the negatively charged phosphate or sialyl- group (Figure 1C–1E).
In addition to this enrichment process, another obvious advantage
of ERLIC over SCX is that few, if any, phosphopeptides and
glycopeptides elute in the flow-through, facilitating their separa-
tions and subsequent MS analysis. As false positive discovery is
always a concern for high throughput analysis, we performed a
control experiment here with the sample preparation procedure
unchanged except without adding PNGase F to the sample in
order to estimate the extent of non-specific deamidation. We
found that 72 NXS/T deamidated sites were identified both in
ERLIC04 and in the control samples. The false positive
glycosylation sites corresponded to 10% of the total in the final
result, which is due to the non-specific deamidaton that happens
spontaneously either in vivo or during the sample preparation.
Comparison of the performance of SCX and ERLIC in the
concurrent analysis of proteome, phosphoproteome and
glycoproteome in rat kidney tissue
For SCX fractionation, a shallow gradient was used to optimize
the separation of phosphopeptides and sialylated glycopeptides
Proteome, Phospho and Glyco-Proteome Analysis by ERLIC
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e16884Figure 1. Chromatograms and peptides distribution. SCX (A) and ERLIC(B) chromatograms ofrat kidney tryptic peptides and distribution oftotal
peptides (C), phosphopeptides (D), and glycopeptides (E). The scales of the Y-axes are different because 214 nm was monitored in (A) and 280 nm in (B).
doi:10.1371/journal.pone.0016884.g001
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tides and glycopeptides identified were eluted before unmodified
peptides, some of them in the flow-through. In ERLIC
fractionation, solvent A was also used as the sample solvent, and
different combinations of solvent A and solvent B were used to
produce different elution gradients for the optimized fractionation
of phosphopeptides and glycopeptides without significantly
affecting the separation of unmodified peptides. The retention
and fractionation of unmodified peptides were successfully
achieved with the solvents used here.
As shown in Figure 2A, the number of proteins identified in
ERLIC04 was the highest in all six fractionation methods, i.e.
2929, better than with the SCX method that is so widely used for
the fractionation of unmodified peptides. As illustrated in
Figure 2B, 338 phosphoproteins and 583 phosphorylation sites
(The MS/MS spectra are shown in Data S1) were identified in
ERLIC04, the highest of the six fractionation methods (158 and
204 percent higher, respectively, than with SCX01 in which 131
phosphoproteins and 192 phosphorylation sites were identified).
The identification of significantly less phosphoproteins in SCX
may be attributed to 1) the loss of some hydrophilic phosphopep-
tides during the desalting step and 2) the distribution of most
phosphopeptides amongst coeluting unmodified peptides. The
better separation and enrichment efficiency of ERLIC can be
another important factor. The number of glycoproteins (387) and
glycosylation sites (722) (The MS/MS spectra are shown in Data
S2) identified in ERLIC04 was also the highest compared with the
other fractionation methods (Figure 2C). The MS/MS spectra for
the identification of phosphopeptides and glycopeptides were
shown in Data S3–S4. For SCX01, 598 glycosylation sites in 353
glycoproteins were identified. In conclusion, ERLIC04 using 80%
ACN, 0.1% FA as buffer A and 10% ACN, 2% FA as buffer B
performed the best in the concurrent fractionation of unmodified
peptides, phosphopeptides and glycopeptides. The complete list of
proteins, phosphoproteins and glycoproteins identified in this
study is supplied in Table S1–S3. Use of salt-containing mobile
phases (e.g., ERLIC01 and ERLIC02) led to a better separation of
modified from unmodified peptides but not to the identification of
more modified peptides. A possible explanation is that the
distribution of phosphopeptides or glycopeptides into more
fractions in the salt-free ERLIC gradient facilitates their MS
analysis.
Annotation of identified phosphorylation and
glycosylation sites with SWISS-PROT database
A total of 583 putative phosphorylation sites and 722 putative
glycosylation sites were identified in the ERLIC04 method via LC-
MS/MS in this study (Figure 2B and 2C). They were annotated by
matching them with the SWISS-PROT database. Among the
identified phosphorylation sites, only 38 were annotated as known
phosphorylation sites, 124 (21.3%) of them were annotated ‘‘by
similarity’’, and 421 (72.2%) were unknown either because the
sites were not annotated in the database or because the
corresponding proteins did not have a SWISS-PROT entry
(Figure 3A). Similarly, for the glycosylation sites, only 4 were
annotated as known glycosylation sites, 312 (43.2%) of them were
annotated ‘‘probable’’, ‘‘potential’’ or ‘‘by similarity’’, and 406
(56.2%) of them were not documented as glycosylation sites or the
corresponding proteins did not have a SWISS-PROT entry
(Figure 3B). These results indicate that phosphorylation and
glycosylation sites are underestimated in the current database. The
strategy presented not only helps to validate known and potential
modification sites but also identifies many new ones. Information
for each identified phosphoprotein and glycoprotein including
protein accession number (IPI), protein description, identified
phosphopeptides or glycopeptides, unique phosphorylation or
glycosylation sites, and their annotation in SWISS-PROT are
listed in Table S2–S3.
The number of phosphorylation and glycosylation sites
identified in this study using one-step enrichment methods was
comparable to those from studies aimed only at either phospho-
proteome or glycoproteome analysis in tissue samples. For
example, Han et al identified 274 phosphorylation sites corre-
sponding to 168 proteins from human liver tissue [37]; Feng et al
reported 163 phosphorylation sites from 133 proteins in mouse
liver lysate [38]; Zhang et al identified 445 glycosylation sites from
prostate cancer tissue and 176 glycosylation sites from bladder
cancer tissue [39]. Of course, the combination of additional
enrichment steps for specific subproteomes would presumably
have resulted in the identification of many more modification sites,
but the incorporation of an additional enrichment step would have
made difficult the simultaneous analysis of unmodified peptides.
Functional analysis of identified proteins,
phosphoproteins and glycoproteins
In total, 2929 proteins, 338 phosphoproteins and 387
glycoproteins were identified in the ERLIC04 method followed
by LC-MS/MS (Figure 2A–2C). Each was categorized according
to their subcellular locations and biological processes using online
Gene Ontology tools in order to determine whether peptides from
particular categories of proteins were significantly enriched. As
shown in Table 1, the subcellular locations of the proteins
identified in whole proteome and subproteome groups were quite
different. Compared with the cellular components of the whole
proteome, some cellular components were better represented in
the phosphoproteome, such as cytoskeleton (7% to 11%) and
nucleus (12% to 19%), while proteins in the extracellular region
(5% to 2%) and mitochondrion (11% to 4%) decreased
significantly. This confirms that peptides from phosphoproteins
are selectively enriched in the ERLIC04 method, and suggests that
phosphorylation mainly happens inside the cells in order to
achieve its regulatory roles in some pathways. As with the
phosphoproteome, some cellular components in the glycopro-
teome also increased significantly relative to the whole proteome:
extracellular region (5% to 13%), proteinaceous extracellular
matrix, (1% to 4%), plasma membrane (10% to 17%), and other
cytoplasmic organelle (5% to 7%). It is noteworthy that less N-
glycoproteins come from cytosol, cytoskeleton, mitochondrion and
nucleus (Table 1), indicating that N-glycosylation mainly occurs on
membrane proteins and extracellular matrix proteins located
outside the cells.
As shown in Table 2, proteins identified from rat kidney tissue
in the ERLIC04 method are involved in various biological
processes such as protein metabolism, RNA metabolism, cellular
component organization, transport and developmental processes.
Here again, the distribution of the phosphoproteins and
glycoproteins identified was found to be different in various
biological processes than that of proteins of the whole proteome.
Compared with the whole proteome, phosphoproteins were more
significantly represented in the biological processes of RNA
metabolism (7% to 10%), DNA metabolism (1% to 2%) and
cellular component organization (9% to 13%), while N-glycopro-
teins were more likely to take part in various processes such as cell
adhesion (2% to 7%), cell-cell signaling (1% to 2%), developmental
processes (8% to 12%), and stress response (6% to 8%). This
suggests again that protein phosphorylation plays important roles
in intracellular processes while protein N-glycosylation is mainly
involved in extracellular processes.
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subproteome enrichment
Since subproteome enrichment reduces the complexity of
samples and facilitates MS analysis, it has been predicted that it
will improve the sensitivity of protein identification significantly
[9]. With the concurrent analysis of proteome, phosphoproteome
and glycoproteome, it is convenient to determine whether
subproteome enrichment improves the sensitivity of protein
identification significantly in a single analysis and reduces the
inter-experimental variation between proteome and subproteome
analysis. In this study, 200 phosphoproteins or glycoproteins were
identified solely from phosphopeptides and/or glycopeptides but
not identified from unmodified peptides in ERLIC04 (Table S4),
suggesting that the subproteome enrichment led to the identifica-
tion of some low-abundance proteins. Based on the functional
analysis using AmiGO Go Slimmer, 9% (27) of these proteins were
Figure 2. Comparison of the efficiency of SCX and ERLIC methods. Comparison of total protein (A), phosphoprotein (B) and glycoprotein (C)
identification in SCX and ERLIC methods using different gradients. For the gradients used in each separation method, see Materials and Methods.
doi:10.1371/journal.pone.0016884.g002
Proteome, Phospho and Glyco-Proteome Analysis by ERLIC
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e16884involved in signal transduction, a significantly higher percentage
than that in whole proteome (5%) and in the phosphoproteome
(6%) and glycoproteome (4%) overall (Table 2). Since most
proteins involved in signal transduction are of relatively low
abundance, the results indicate that subproteome enrichment
improves the sensitivity of identification of low-abundance
proteins. Checking the listings of these 27 proteins in the
SWISS-PROT database: 23 of them (85.2%) were annotated
‘‘evidence at transcript level’’; 1 had no SWISS-PROT entry; only
3 were annotated ‘‘evidence at protein level’’. This sketchy record
seems to confirm that most of them are of low abundance.
In addition, subproteome enrichment leads to the identification
of many low-abundance proteins with known important functions
that cannot be identified from whole proteome analysis. For
example, integrin alpha-5/beta-6 and angiopoietin-like 3 are
identified only in the PTM-enriched fraction. Integrin alpha-5/
beta-6 is a receptor for fibronectin and cytotactin, and their
binding inhibits tumor growth, angiogenesis and metastasis [40].
Angiopoietin-like 3, present at extremely low levels in kidney, can
bind integrin alpha-5/beta-3, which induces cell adhesion and
migration and regulates angiogenesis [41]. The expression of
many other cancer related genes, such as CD63, CD36, Cd164,
Gpld1, Ace and Braf, was also detected only from the set of
enriched modified peptides.
The occurrence of partial phosphorylation on some
phosphorylation sites
Protein phosphorylation can vary quickly in response to
intracellular or extracellular stimuli independent of protein
expression, and a change in phosphorylation level of some
proteins may be an indicator of physiological state [19].
Sometimes a change in protein phosphorylation also accompanies
a protein’s expression [42]. Thus, it is necessary to distinguish
between the two. The presented method (ERLIC04) for
concurrent analysis of proteome and subproteomes is a promising
means of doing so. By comparing phosphopeptides with
unmodified peptides identified here, the corresponding unmodi-
fied peptides were found for 96 unique phosphopeptides in 84
Figure 3. Annotation of identified phosphorylation and glycosylation sites. Matches of identified phosphorylation sites (A) and
glycosylation sites (B) were with the SWISS-PROT knowledge database of Rattus.
doi:10.1371/journal.pone.0016884.g003
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phosphopeptide of LCLpSTVDLEVK was eluted 11 fractions
later than its unmodified form, due of course to the phosphate
group that prolongs its retention in the ERLIC mode. The
phosphorylation level of the protein at this site was estimated to be
about 51% using the peak intensities of the extracted ion
chromatogram (XIC) of the phosphopeptide and its unmodified
form. This estimate presumes that they ionize with equal
efficiency, which may or may not be the case.
The MS/MS spectra of the peptide of LCLpSTVDLEVK and
its unmodified form are shown in Figure 4B and 4C, respectively.
In the MS/MS spectrum, its phosphorylation site is sandwiched by
fragments still bearing the modification as well as the correspond-
ing neutral loss (-98Da) fragments, i.e. y4, y5, y6, y7, y8-98, y8, y9-
98, y9, y10, which validates the phosphorylation site assignment.
Phosphoproteins with substoichiometrically phosphorylated
sites were categorized according to their subcellular locations
and biological processes using Amigo Go Slimmer. As shown in
Figure 4D and 4E, partial phosphorylation can occur on proteins
in all biological processes and subcellular locations except for
proteinaceous extracellular matrix. In comparison with that of
total phosphoproteins in Table 1, partial phosphorylation is more
likely to happen in mitochondria (6% versus 4%) and other
membranes (29% versus 23%), and it also tends to occur on
proteins involved in the biological process of transport (16% versus
9%). Of the 8 partially phosphorylated mitochondrion proteins
identified in this study, 5 of them are involved in transport. For
example, monocarboxylate transporter 1 is a proton-linked
monocarboxylate transporter that catalyzes the rapid transport
across the plasma membrane of many monocarboxylates;
mitochondrial import receptor subunit TOM70 is a receptor to
accelerate the import of all mitochondrial precursor proteins; 14-
3-3 protein zeta/delta and 14-3-3 protein epsilon are adapter
proteins involved in many general and specialized signaling
pathway, and their interactions generally affects the activity of
the binding partners. However, it is still elusive how partial
phosphorylation affects the function of these proteins. Partial
phosphorylation has been reported in the regulation of transport
process. For example, the phosphorylation degree of tau protein
regulates its axonal transport by controlling its binding to kinesin
[43]; dysregulation of tau phosphorylation is observed in
Alzheimer’s disease [44]; cyclin-dependent kinase 5 can increase
the phosphorylation degree of perikaryal neurofilament and
inhibits neurofilament axonal transport in response to oxidative
stress [45]; and the phosphorylation degree of the nuclear
transport machinery has been reported to negatively regulate
entire nuclear transport pathways for the global control of cellular
activities [46]. The systematic study of partial phosphorylation will
deepen the understanding of its roles in other biological processes.
The occurrence of partial N-glycosylation on some
glycosylation sites
The role of partial N-glycosylation in glycoproteins has seldom
been studied because most current glycoprotein analysis methods
are incapable of distinguishing partially from fully glycosylated
sites. In this study, by comparing glycopeptides with unmodified
peptides identified by the ERLIC04 method, the corresponding
unmodified peptides were identified for 60 unique glycopeptides in
53 glycoproteins (Table S6). As shown in Figure 5A, the
glycopeptide of GVVDSDDLPLgNVSR eluted 8 or 9 fractions
later than its unmodified form, a significant shift for so acidic a
peptide. This is evidence of the degree to which the negative
charge from sialic acid residues (and possibly the hydrophilic
interaction with the rest of the glycan) prolongs retention in
ERLIC. The glycosylation level at this site in vivo was estimated to
be about 1.2% using the peak intensity of the XICs of the
glycopeptide and its unmodified form, indicating that our strategy
is very sensitive in detecting partial glycosylation. The MS/MS
spectra of the peptide of GVVDSDDLPLgNVSR and its
unmodified form are shown in Figure 5B and 5C, respectively.
In the MS/MS spectrum, its glycosylation site is sandwiched
between fragments with the deamidated asparagine (aspartic acid),
i.e. b12, b13, y6 and y8-y12, the mass of which was about 0.98 Da
Table 1. Gene ontology classification of identified proteins,
phosphoproteins and glycoproteins in ERLIC04 according to
their respective subcelluar locations using AmiGo Go Slimmer
online annotation tools.
Subcellular location Proteins Phosphoproteins Glycoproteins
Cytoskeleton 7% 11% 2%
Cytosol 10% 10% 4%
ER/Golgi 8% 7% 8%
extracellular region 5% 2% 13%
mitochondrion 11% 4% 6%
Nucleus 12% 19% 4%
other cell component 6% 6% 5%
other cytoplasmic
organelle
5% 5% 7%
other membranes 24% 23% 30%
plasma membrane 10% 12% 17%
proteinaceous
extracellular matrix
1% 1% 4%
doi:10.1371/journal.pone.0016884.t001
Table 2. Gene ontology classification of identified proteins,
phosphoproteins and glycoproteins in ERLIC04 according to
their respective biological processes using AmiGo Go Slimmer
online annotation tools.
Biological process Proteins Phosphoproteins Glycoproteins
biological_process 5% 5% 4%
cell adhesion 2% 2% 7%
cell cycle or
proliferation
5% 6% 5%
cell-cell signaling 1% 1% 2%
cellular component
organization
9% 13% 9%
cell death 4% 5% 3%
developmental
processes
8% 9% 12%
DNA metabolism 1% 2% 1%
other metabolic
processes
24% 20% 21%
protein metabolism 10% 9% 11%
RNA metabolism 7% 10% 3%
signal transduction 5% 6% 4%
stress response 6% 5% 8%
transport 11% 9% 11%
doi:10.1371/journal.pone.0016884.t002
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MS/MS spectrum of the unmodified peptides. This further
validates the assignment of the glycosylation site.
The glycoproteins with partially glycosylated sites were also
categorized according to their subcellular locations and biological
processes using Amigo Go Slimmer. As shown in Figure 5D and
5E, partial glycosylation can occur on proteins in all of the
subcellular locations and biological processes except for RNA
metabolism and transcription. However, when compared with the
distribution of glycoproteins listed in Table 1, partial glycosylation
tends to happen on cytoskeleton (4% versus 2%), nucleus (7%
versus 4%) and other cytoplasmic organelles including endosome,
lysosome and vacuole (11% versus 7%), and is also prone to occur
on proteins involved in the biological process of cellular
component organization (11% versus 9%) and transport (15%
versus 11%). Altered N-glycosylation was reported to reduce but
not completely eliminate intracellular transport of lactase-phlorizin
hydrolase to the microvillus membrane in rat small intestine [47].
Another study, about human solute carrier PAT1, reported that
N-glycans are not essential for transport function but are
important for membrane targeting [48]. The degree of N-
glycosylation may play important roles in controlling the rate of
transport. To the best of our knowledge, there are still no reports
about the role of partial N-glycosylation in cellular component
organization. The list of partially glycosylated proteins discovered
in this study will be helpful to an understanding of its biological
significance.
Analysis of proteins with both phosphorylation sites and
glycosylation sites
In this study, the concurrent analysis of proteome, phospho-
proteome and glycoproteome led to the identification of 12
proteins with both phosphorylation and glycosylation, of which
11 were membrane proteins or extracellular matrix proteins.
T h ee x i s t e n c eo ft h er e m a i n i n go n ew a so n l yp r e d i c t e df r o m
the DNA. Information for each of them including protein
accession number and annotation in SWISS-PROT, protein
description, functions, and unique phosphorylation or glyco-
sylation sites are listed in Table S7. Some of the proteins were
found to be involved in both intracellular and extracellular
processes. For example, versican core protein may play a role
in intercellular signaling and in connecting cells with the
extracellular matrix, and it may also be involved in the
regulation of cell motility, growth and differentiation. Its
phosphorylation sites have been predicted to be present in
the extracellular domain in SWISS-PROT. As an extracellular
matrix protein, fibronectin plays a major role in cell adhesion,
growth, migration and differentiation [49]. It induces fibril
formation after binding to anastellin, and the fibronectin
polymer enhances cell adhesion so that tumor growth,
angiogenesis and metastasis can be inhibited. It is reported
that altered fibronectin expression, degradation and organiza-
tion is closely related to many diseases including cancer and
fibrosis [40]. Fibronectin not only exhibits functions typical of
N-glycoproteins, but also signals to intracellular spaces via
adhesion receptors, i.e. the typical functions of phosphopro-
teins. The formation of fibronectin and integrin complex results
in a range of downstream effects, including phosphorylation of
FAK [50]. FAK has been found to be directly involved in
sensing the extracellular matrix and responding efficiently to
the changing microenvironment [51]. Thus, fibronectin suc-
cessfully connects intracellular events with the changes of
extracellular matrix, which are closely related to glycoproteins.
However, other proteins in Table S7 have been less studied
with few functional annotations in SWISS-PROT. In the past,
the study of N-glycosylation and phosphorylation has been
conducted independently, which prevented the elucidation of
the relationship between phosphorylation and N-glycosylation
in the same protein. The present strategy will facilitate such
analysis by identifying proteins with both these major
modifications.
Comparison of the ERLIC approach with two previously
published ERLIC based approaches
We have published two novel ERLIC based fractionation
approaches for the simultaneous characterization of glyco- and
phosphoproteomes of mouse brain membrane [29] and the
comprehensive profiling of rat kidney proteome [30]. In the first
one, both glycopeptides and phosphopeptides were selectively
enriched due to their hydrophilic interaction and/or electrostatic
interaction of the negative charged phosphoric and sialyl groups
with the stationary phase of the ERLIC column, but most
unmodified peptides were excluded as flow-through since they
were repelled by the stationary phase at 70% ACN at pH 2. In the
second one, 90% ACN/0.1% acetic acid was used as mobile phase
A so that nearly all peptides will be retained on the ERLIC column
through hydrophilic and/or electrostatic interactions, and they
were evenly distributed into multiple fractions based on both pI
and polarity when eluted using a shallow gradient of increasing
water content and decreasing pH value. However, both glyco-
peptides and phosphopeptides cannot be characterized effectively
due to their sub-stoichiometric amounts and the ionization
suppression from unmodified peptides. In this study, we further
optimized the ERLIC conditions so that as many as unmodified
peptides were retained and fractionated by the column when
phosphopeptides and glycopeptides were enriched. Its limitation is
that both the analysis of modified peptides and unmodified
peptides was compromised to a certain extent compared with the
two previously published approaches. However, it provided a
global analysis of both unmodified peptides and modified peptides
in one run, which could not be achieved with the two previously
published ERLIC approaches. It was also capable of detecting
partial phosphorylation and N-glycosylation with potential
biological significance regarding the control of some biological
processes, such as cellular component organization and transport.
At the same time, it identified some proteins having both these
modifications, which would facilitate the future evaluation of cross-
talk between these two vital PTMs.
In the future, when the present method is employed together
with some quantitative methods, such as SILAC, iTRAQ or label-
free quantification methods, it will be capable of assessing the
changes in protein expression and these two PTMs in one analysis,
which reduces the inter-experimental variations in the quantita-
tion. Better understanding of substoichiometric modifications may
be helpful in elucidation of how some biological processes are
controlled inside the cell.
Figure 4. The occurrence of partial phosphorylation of a representative peptide. The ERLIC chromatogram shows the fractions in which
the phosphopeptide and its unmodified form were eluted (A); Representative MS/MS spectra for identification of the phosphopeptide (B) and its
unmodified form (C); Gene ontology analysis of partially phosphorylated proteins according to their subcellular locations (D) and biological processes
(E) using AmiGo Go Slimmer.
doi:10.1371/journal.pone.0016884.g004
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